Newsletter Subject

This System Has Failed You... Now It Can PAY You

From

markettickerpress.com

Email Address

editor@markettickerpress.com

Sent On

Sat, Jun 10, 2023 11:01 PM

Email Preheader Text

This is a must read. If you cannot see this email properly, please click This System Has Failed You.

This is a must read. If you cannot see this email properly, please click [here]( This System Has Failed You... Now It Can PAY You --------------------------------------------------------------- More than twenty years ago, I left a lucrative career on Wall Street to study medicine. I became an eye surgeon. But I soon learned that [American medicine is just as rotten and corrupt as American finance.]( So I left medicine too - and started a third career, writing about stocks... and helping ordinary folks learn how to retire wealthy and worry-free. Believe me, I know how badly these systems have failed you. How much aggravation they've probably caused. [But if you've ever wanted to stick it to either one of them - you urgently need to see this.]( It's a huge development I've waited 40 years for... Creating the biggest moneymaking opportunity I've ever seen in my life. And it's happening while everyone is distracted by the crashing market. I'm telling you - as a physician, medical researcher, MBA, and market analyst for decades - [it's time to pay attention to this one inflation- and recession-resistant sector.]( Health and medicine are undergoing a radical transformation. Trillions are changing hands. And the COVID-19 crisis put this transformation on steroids. The research firm Forrester reported that health care "accelerated by a decade in a matter of months." And the CEO of Johnson & Johnson just went on record predicting that "the next 10 years will bring greater medical innovation than the last 100 years combined." When [you've seen this...]( I guarantee you'll never look at the health care system... your own health decisions... or your investing dollars.... the same way ever again. This information could lead you to a series of triple-digit gains... maybe even save your life or the life of someone you love. [That's why I'm sharing the most important research of my life, completely for free, at this private link.]( Here's to our health, wealth, and a great retirement, Dr. David Eifrig, MD, MBA Senior Partner, Stansberry Research This ad is sent on behalf of Stansberry Research, 1125 N Charles St, Baltimore, MD 21201. If you would like to optout from receiving offers from Stansberry Research please [click here](. Market Ticker Press Disclaimer This newsletter contains advertisements which are neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this newsletter or email is not provided to any individual with a view toward their individual circumstances. Compensation for advertising constitutes a conflict of interest as to our ability to remain objective in our communication regarding any companies profiled. Because of this conflict, individuals are strongly encouraged to not use this newsletter as the basis for any investment decision. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment. By opening and/or clicking a link containted within this email, you are reconfirming your opt-in status. You can unsubscribe at any time. MarketTickerPress.com part of Sandpiper Marketing Group | 1519 Mecklenburg Hwy | Unit 4 | Mt. Mourne | North Carolina | 28123 | United States | 877-411-9808 [Unsubscribe]( | [Report spam]( Sent with [ActiveTrail]( software

Marketing emails from markettickerpress.com

View More
Sent On

04/03/2024

Sent On

03/03/2024

Sent On

03/03/2024

Sent On

03/03/2024

Sent On

02/03/2024

Sent On

02/03/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2024 SimilarMail.